Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 16/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 9/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 10/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19861940 | 0.91 | HDAC4 (0.43) | HDAC6HDAC1HDAC8HDAC4HDAC5 | |
| SCHEMBL21215295 | 0.88 | HDAC6 (0.49) | HDAC6HDAC1HDAC8HDAC4HDAC5 | |
| SCHEMBL19861927 | 0.86 | HDAC6 (0.47) | HDAC6HDAC1HDAC8HDAC4HDAC5 | |
| SCHEMBL19861941 | 0.85 | HDAC6 (0.44) | HDAC6HDAC1HDAC8HDAC4NR1I2 | |
| SCHEMBL19030851 | 0.81 | HDAC4 (0.50) | HDAC6HDAC1HDAC8HDAC4 | |
| SCHEMBL19861945 | 0.81 | HDAC4 (0.50) | HDAC6HDAC1HDAC8HDAC4 | |
| SCHEMBL19030850 | 0.81 | HDAC4 (0.50) | HDAC6HDAC1HDAC8HDAC4 | |
| SCHEMBL19861928 | 0.80 | HDAC6 (0.45) | HDAC6HDAC1HDAC8HDAC4HDAC5 | |
| SCHEMBL19861921 | 0.77 | HDAC6 (0.50) | HDAC6HDAC1HDAC8HDAC4HDAC5 | |
| SCHEMBL19861933 | 0.76 | HDAC1 (0.43) | HDAC6HDAC1HDAC8HDAC4HDAC5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10980233-B2 | Oxadiazole compound and use thereof as pesticides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-04-20 | — | — | US | disclosed |
| US-20190230928-A1 | OXADIAZOLE COMPOUND AND USE THEREOF AS PESTICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-08-01 | — | — | US | disclosed |
| WO-2018030460-A1 | OXADIAZOLE COMPOUND AND USE THEREOF AS PESTICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10980233-B2 | Oxadiazole compound and use thereof as pesticides | RXFP3, OXER1, OXA1L | HDAC6 1746/4885HDAC1 660/4885HDAC8 2524/4885 |
| US-20190230928-A1 | OXADIAZOLE COMPOUND AND USE THEREOF AS PESTICIDES | RXFP3, OXER1, OXA1L | HDAC6 1746/4885HDAC1 660/4885HDAC8 2524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.